HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.

Abstract
Dendritic cells (DCs) are antigen-presenting cells efficient in capturing pathogens, and processing their antigenic determinants for presentation to antigen-specific T cells to induce robust immune responses. Their location at peripheral tissues and the expression of pattern-recognition receptors, among them DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), facilitates the capture of pathogens before spreading. However, some pathogens have developed strategies to escape the immune system. One of the most successful is HIV-1, which targets DC-SIGN for transport to the lymph node where the virus infects CD4(+) T cells. Contact of HIV-1 with DC-SIGN is thus the first event in the pathogenic cascade and, therefore, it is the primary target point for therapies aimed at HIV infection prevention. DC-SIGN recognizes specific glycans on HIV-1 and this interaction can be blocked by competitive inhibition through glycans. Although the affinity of glycans is relatively low, multivalency may increase avidity and the strength to compete with HIV-1 virions. We have designed multivalent dendrimeric compounds based on Lewis-type antigens that bind DC-SIGN with high selectivity and avidity and that effectively block gp120 binding to DC-SIGN and, consequently, HIV transmission to CD4(+) T cells. Binding to DC-SIGN and gp120 inhibition was higher on glycodendrimers with larger molecular diameter, indicating that the geometry of the compounds is an important factor determining their functionality. Our compounds elicited DC-SIGN internalization, a property of the receptor upon triggering, but did not affect the maturation status of DCs. Thus, Le(X) glycodendrimers could be incorporated into topic prophylactic approaches for the prevention of HIV-1 transmission.
AuthorsJuan J Garcia-Vallejo, Nathalie Koning, Martino Ambrosini, Hakan Kalay, Ilona Vuist, Ramin Sarrami-Forooshani, Teunis B H Geijtenbeek, Yvette van Kooyk
JournalInternational immunology (Int Immunol) Vol. 25 Issue 4 Pg. 221-33 (Apr 2013) ISSN: 1460-2377 [Electronic] England
PMID23291968 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell Adhesion Molecules
  • DC-specific ICAM-3 grabbing nonintegrin
  • Dendrimers
  • HIV Envelope Protein gp120
  • Lectins, C-Type
  • Lewis Blood Group Antigens
  • Polysaccharides
  • Receptors, Cell Surface
Topics
  • Binding, Competitive
  • Cell Adhesion Molecules (agonists, immunology)
  • Cell Differentiation (drug effects)
  • Cells, Cultured
  • Dendrimers (chemistry)
  • Dendritic Cells (drug effects, immunology, virology)
  • HIV Envelope Protein gp120 (metabolism)
  • HIV Infections (prevention & control, transmission)
  • HIV-1 (immunology)
  • Humans
  • Immune Evasion
  • Lectins, C-Type (agonists, immunology)
  • Lewis Blood Group Antigens (chemistry)
  • Molecular Targeted Therapy
  • Polysaccharides (agonists, chemical synthesis, pharmacology)
  • Receptors, Cell Surface (agonists, immunology)
  • Structure-Activity Relationship
  • Virus Internalization (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: